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transitions from state to any other state in the data and then divides the counts by
the number of occurrences for each . The VARmethod follows Tauchen (1986) and
Terry and Knotek (2011). We compare the two methods using Monte Carlo simula-
tions by generating small samples from different data generating processes (DGPs)
and comparing the mean squared errors made by each method versus the true
transition matrix. We employ two DGPs to populate the entries of our underlying
transition probability matrices in our study: 1) A normal distribution with large
variance (DPG1), and 2) a uniform distributionwith small variance (DGP2). We then
normalize each row so they sum to 1. RESULTS: In DGP1, the VAR outperforms the
count method in small samples (N  10 or 30) and the count method marginally
outperforms the VAR method in the large sample (N  50). For DGP2, VAR outper-
forms in small samples and both methods perform similarly in the large sample.
We propose a combination of the two methods by increasing the weight on the
count method when the sample size increases relative to the size of the matrix.
CONCLUSIONS: By applying this methodology in Health Economics modeling, it
allows the researcher to utilize Markov models in situations previously infeasible
due to a paucity of data.
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OBJECTIVES:Willingness-to-pay (WTP) analysis is a method for the monetization
of a population’s preference for a particular medication and may be determined
using a bidding game where participants are asked if they would be willing to pay
a particular amount, starting with a pre-determined value and oscillating between
a series of new WTP amounts based on their previous answer. Starting point bias
has been previously reported in the literature. The objective of the present study
was to ascertain if any bias was introduced by applying higher or lower starting
values to a bidding game. METHODS: An online survey was presented to mem-
bers of the general public in Ontario, Canada, who were presented with two
treatment delivery options (inhaler vs. injection) for a treatment of pulmonary
arterial hypertension. Participants who selected the inhaler were randomly as-
signed a starting value (CAD$1, $2 or $5) and were asked to identify their WTP in
terms of additional monthly insurance premiums. The minimum and maxi-
mum bidding game values were set at CAD$0.01 and CAD$50.00; participants
who agreed to pay CAD$50.00 were allowed to input a higher WTP explicitly, as
desired. The Kruskall-Wallis non-parametric test was applied to explore the
differences in mean WTP associated with each starting value. RESULTS: Eighty-
six participants reported a meanWTP of CAD$43.15 for the inhaler in additional
monthly insurance premium. The mean WTP were CAD$37.55, CAD$49.36 and
CAD$40.31 for participants whowere assigned to a starting point of CAD$1, $2 or
$5, respectively. No significant difference in WTP values was observed between
the groups. CONCLUSIONS:The starting value did not appear to introduce a bias in
the bidding game.
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OBJECTIVES: Different countries might have similar health preferences due to
cultural or economic factors. The aim of this study is to identify whether there are
groups of countrieswith similar health-state valuations.METHODS:A cluster anal-
ysis was performed for the 242 states of the EQ-5D valuations for 23 published
studies in 18 countries. The perfect health state was not included. The Ward algo-
rithm with the Euclidean measure and the hierarchical clustering technique were
used in order to identify the optimal number of clusters and the clusters them-
selves. The features of the resulting clusters were studied and whether there were
similarities in the countries belonging to the same cluster. The effect of the valu-
ation methodology, Visual Analogue Scale (VAS) or Time Trade Off (TTO), was also
taken into account. RESULTS: Five clusters were identified: 1) Germany-TTO, Neth-
erlands-TTO, Denmark-TTO, Argentina-TTO, Poland-TTO; 2) Belgium-VAS, Eu-
rope-VAS, New Zealand-VAS, Spain-VAS, UK-VAS, Denmark-VAS, Germany-VAS,
Slovenia-VAS; 3) Spain-TTO, UK-TTO; 4) Japan-TTO, USA-TTO, Zimbabwe-TTO,
Hispanic USA-TTO, South Korea 2009-TTO, Finland-VAS, Argentina, VAS; and 5)
South Korea 2008-TTO. Valuations are very sensitive to the preference elicitation
methodology. Hence, valuations for a country may be more similar to the valua-
tions of another country with the same methodology than to the same country
with a different methodology. Countries in the same cluster tend to have cultural
similarities (e.g. European countries with the same methodology tend to belong in
the same cluster) but a particular cluster grouped otherwise dissimilar countries
and methodologies: Japan-TTO, USA-TTO, Zimbabwe-TTO, and Argentina-VAS.
CONCLUSIONS: Health-state valuations tend to be clustered in a few groups of
countries that share cultural or economic features. These results can be used in
sensitivity analyses when performing cost-utility analysis.
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OBJECTIVES: Health economics research aims to maximise health gain within a
given budget constraint, and is predominantly achieved through themaximisation
of the quality-adjusted-life-year (QALY). Historically, the QALY assumes that indi-
viduals derive utility only from the consequences of processes and not from the
processes themselves. This assumption of narrow consequentialism suggests
health care consumers gain no benefit from the consumption of health, but that its
value is determined exclusively through health outcomes. There is growing inter-
est, however, in being able to differentiate between treatments with different pro-
cesses, such as delivery methods, in quantitative terms. This study aimed to iden-
tify and review published empirical studies which include a measure of process
utility (PU) which could be incorporated into the QALY calculation. METHODS: A
literature reviewwas performed inMedline using the search term “process utility”.
Additional searcheswere performed to identify studies not using this specific term,
for example: treatment-related attributes AND (utilities OR utility
measurement). RESULTS: Fifteen studies were identified. A variety of approaches
were used to detect and measure PU: 4 studies used standard-gamble techniques;
5 studies used time-trade-off techniques; 2 studies used conjoint analysis; 1 study
used SF-36 data; 3 studies used waiting-trade-off techniques. Eight studies evalu-
ated treatments: 5 in diabetes and the remainder in gallstone disease, HIV and pain
treatments; 6 studies evaluated testing/screening procedures and 1 study evalu-
ated preventative care. All studies identified the presence of PU. Utility decrements
ranged from 0.03-0.14 for different drug delivery methods, and 0.0005-0.12 for dif-
ferent dosing strategies. CONCLUSIONS:Although there is no universally accepted
methodology for the detection and measurement of PU, evidence to date does
support its existence. Thewide range in values and approaches suggests that stan-
dardisation of methods around the most valid approach is highly desirable. With-
out this type of consensus, comparability and validity of results will be limited.
PRM38
VALIDATION OF NEW MEASURES OF PATIENTS’ POST-TRANSPLANT
EXPERIENCE IN THE PATIENTSLIKEME® ORGAN TRANSPLANT COMMUNITY
Massagli MP1, Gnanasakthy A2, Wicks P1
1PatientsLikeMe, Cambridge, MA, USA, 2Novartis Pharmaceuticals Corporation, East Hanover,
NJ, USA
OBJECTIVES: To study post-transplant experience of disease and treatment among
members of the free online PatientsLikeMe® Organ Transplant Community.
METHODS: A review of the literature, existing questionnaires, and analysis of dis-
cussions between transplant recipients on the website PatientsLikeMe.com was
used to generate items for a survey in patients’ own voice. Cognitive debriefing
(n7) was used to refine the items. Including patient and treatment characteristics
the resulting online questionnaire contained 170 items informing 17 dimensions of
patient experience. We surveyed patients in the US who had received a single
organ. RESULTS: Twenty-eight percent of current, sampledmembers responded (n
 116, median completion time  22 minutes). The sample was 63% female, 72%
aged 45 or older, 77% non-Hispanic white, 41% college graduate, 62% kidney recip-
ients, 70% transplanted 2 or more years ago. There were no significant differences
between respondents and non-respondents. Over 40% of respondents rated their
health as very good or excellent; over 60% rated their life since transplant as
better than expected. On average, 7 symptoms (of 41) were reported as at least
moderately bothersome in the past 4 weeks. More symptoms correlated with
worse experience of physical, mental, emotional, and social functions and rela-
tionswith the health care team. Patientswithmore symptoms also reported poorer
immunosuppressant adherence (F4,1252.66, p  0.036). Regression analysis
showed that disease-specific impact and physical limitation were most important
to overall status. Analysis of variance showed the scales varied in sensitivity to
reported group differences in overall health, perceived adherence, and comparison
of current situationwith what the patient expected. Reliability was above .79 for 15
of 18 scales. Scale correlations were moderate. CONCLUSIONS: Using the Patient-
sLikeMe online Organ Transplantation community questions were adapted from
existing PROmeasures andnewquestionswere developed tomeasure both generic
and condition-specific experiences important to post-transplant patients.
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OBJECTIVES: Starting point (SP) bias has been reported in somewillingness-to-pay
(WTP) analyses using a bidding game (BG) approach. The objective of the present
study was to systematically reviewWTP analyses which used more than one SP to
ascertain if any bias was observed. METHODS: Using OVID MEDLINE® for 1996-
2011 and the keywords [Bidding AND (Willingness to payORWillingness-to-pay OR
WTP)], two reviewers independently identified and examinedWTP analyses which
applied more than one SP to a BG approach and which discussed any associated
bias. Additional publications were also extracted from the references of relevant
articles. Any discrepancy between the two reviewers was resolved through
consensus. RESULTS: From 51 articles yielded by the literature search, 12 met the
inclusion criteria and a further 5 were classified as secondary evidence (publica-
tions reporting on SP bias without presenting numerical data). Relevant publica-
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